Evolent Health A Aktie
8,10
EUR
+0,70
EUR
+9,46
%
9,25
USD
+0,60
USD
+6,88
%
Werbung
Evolent Health A Aktie Analyse
01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
13.07.16 | Evolent Health A Outperform | FBR Capital | |
29.03.16 | Evolent Health A Outperform | FBR Capital | |
06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung